1Abnormal ERK/MAPK pathway activity is an important contributor to the neuropathogenesis of 2 many disorders including Fragile X, Rett, 16p11.2 Syndromes, and the RASopathies. Individuals with these 3 syndromes often present with intellectual disability, ADHD, autism, and epilepsy. However, the 4 pathological mechanisms that underly these deficits are not fully understood. Here, we examined whether 5 hyperactivation of MEK1 signaling modifies the development of GABAergic cortical interneurons (CINs), 6 a heterogeneous population of inhibitory neurons necessary for cortical function. We show that 7 GABAergic-neuron specific MEK1 hyperactivation in vivo leads to increased cleaved caspase-3 labeling 8 in a subpopulation of immature neurons in the embryonic subpallium. Adult mutants displayed a significant 9 loss of mature parvalbumin-expressing (PV) CINs, but not somatostatin-expressing CINs, during postnatal 10 development and a modest reduction in perisomatic inhibitory synapse formation on excitatory neurons.
11Surviving mutant PV-CINs maintained a typical fast-spiking phenotype and minor differences in intrinsic 12 electrophysiological properties. These changes coincided with an increased risk of seizure-like phenotypes. 13 In contrast to other mouse models of PV-CIN loss, we discovered a robust increase in the accumulation of 14 perineuronal nets, an extracellular structure thought to restrict plasticity in the developing brain. Indeed, we 15 found that mutants exhibit a significant impairment in the acquisition of a behavioral test that relies on 16 behavioral response inhibition, a process linked to ADHD-like phenotypes. Overall, our data suggests PV-17